For decades, antiviral immunity has been described as a molecular surveillance system built to distinguish the genetic material of invading viruses from the RNA normally produced by a healthy cell. A new study in Nature Immunology suggests that this picture is incomplete. Sampaio, Davis, Gearing and colleagues report that viral infection can disrupt the cell’s own RNA-processing and RNA-clearance systems, creating abnormal RNA molecules that help activate the innate immune sensor MDA5. The findings place the loss of cellular RNA homeostasis—rather than the mere presence of foreign genetic material—at the centre of an important pathway that determines how cells detect infection and launch an interferon response.
MDA5, or melanoma differentiation-associated protein 5, is a member of the RIG-I-like receptor family. These proteins patrol the cytoplasm for RNA structures that are unusual in healthy cells. MDA5 is particularly responsive to long stretches of double-stranded RNA, a molecular form commonly generated during the replication of many RNA viruses. When MDA5 binds such RNA, it assembles into filament-like structures and engages the adaptor protein MAVS on mitochondria and related membranes. MAVS then activates kinase cascades that stimulate transcription factors including IRF3, IRF7 and NF-κB, leading to production of type I and type III interferons and a broad collection of interferon-stimulated genes.
The challenge is that double-stranded or highly structured RNA is not exclusive to viruses. Mammalian cells constantly produce RNA molecules that can fold into duplexes, form long repetitive structures or become joined to other transcripts through abnormal processing. Under normal conditions, these potentially immunogenic molecules are edited, trimmed, compartmentalised or destroyed before they can trigger innate immune receptors. Cellular RNA homeostasis therefore acts as a form of immune restraint. The study’s central conclusion is that infection can weaken this restraint, allowing endogenous RNA species to accumulate or change in ways that make them visible to MDA5.
This distinction is important because it changes how researchers may interpret MDA5 activation during infection. The sensor may not always be responding directly to a large quantity of viral double-stranded RNA. Instead, viral replication could interfere with several layers of RNA metabolism, including transcription, splicing, maturation, export, surveillance and degradation. The resulting imbalance would increase the supply of abnormal host-derived RNA in the cytoplasm. Some of these molecules may contain extensive duplex regions or other structural features that resemble viral replication intermediates. In this model, the antiviral alarm is initiated by a combination of viral RNA and the cellular damage caused by infection.
The researchers used experimental approaches designed to connect RNA metabolism with innate immune signalling rather than treating the two processes as separate events. Their analyses examined how infection changes the abundance, structure and processing state of cellular RNA, and then assessed how these changes affect MDA5-dependent responses. By perturbing components of RNA surveillance and comparing cells with intact or impaired MDA5 signalling, the work linked defects in RNA control to interferon production. Such experiments are technically demanding because immunogenic RNA can be transient, highly structured and difficult to recover without altering its natural state. They also require separating host transcripts from viral RNA and distinguishing direct receptor activation from secondary effects of inflammation.
The emerging mechanism has several possible molecular layers. RNA molecules that are normally removed by nuclear or cytoplasmic quality-control pathways may escape degradation when infection changes the activity or location of RNA-processing factors. Viral proteins can redirect cellular enzymes, remodel membranes and alter the movement of RNA between the nucleus and cytoplasm. Infection can also disturb the balance between RNA synthesis and decay, increasing the chance that incomplete transcripts, improperly spliced RNAs or repetitive sequences will persist. Once exposed in the cytoplasm, these molecules can pair with complementary regions, generating double-stranded structures long enough to engage MDA5. The study therefore presents RNA quality control as an active component of antiviral defence, not simply as housekeeping.
MDA5 signalling is powerful but potentially hazardous. Interferons establish an antiviral state in neighbouring cells by inducing hundreds of genes that inhibit viral entry, translation, genome replication and particle production. At the same time, excessive or prolonged interferon signalling can damage tissues and contribute to inflammatory disease. The new findings offer a possible explanation for why disturbances in RNA processing are associated with autoimmune and autoinflammatory disorders. If endogenous RNA repeatedly escapes surveillance, MDA5 and downstream pathways could be activated in the absence of an ongoing infection. Conversely, viruses that suppress RNA decay or alter RNA structure might manipulate the same system to delay detection or provoke harmful inflammation.
The work also helps explain why different viruses can produce markedly different innate immune outcomes even when they replicate to similar levels. A virus that generates abundant double-stranded replication intermediates may activate MDA5 directly, whereas another may provoke a stronger response by disrupting host RNA maturation. Viral antagonists that target RNA-binding proteins, nucleases or intracellular transport pathways could reshape the host RNA landscape without eliminating viral RNA sensing altogether. The immune response would then depend not only on the virus’s genome and replication strategy, but also on the specific cellular RNA-control networks that it perturbs. This may be one reason why the same infection can trigger distinct interferon patterns in different cell types.
The findings could influence the design of antiviral therapies and immune-modulating treatments. Drugs that preserve host RNA surveillance might reduce inappropriate MDA5 activation and limit inflammatory injury, while treatments that deliberately increase the visibility of infected cells’ RNA could strengthen responses against viruses that evade direct sensing. Any such strategy would need to be carefully calibrated. Enhancing the accumulation of immunogenic RNA could improve viral control but might also produce systemic interferon toxicity. The study points toward a more precise objective: identifying the particular RNA-processing failures that distinguish productive infection from harmless cellular stress, and targeting those failures without broadly disrupting the essential functions of RNA metabolism.
More broadly, the research expands the concept of pathogen sensing from the recognition of foreign molecules to the recognition of disrupted molecular order. Cells appear to monitor not only whether viral RNA is present, but also whether the systems that normally keep RNA properly processed, localised and degraded are still functioning. When those systems fail, the resulting molecular debris can become an alarm signal. By showing that loss of RNA homeostasis contributes to MDA5 activation, the study connects virology, RNA biology and immunology in a single mechanism. It suggests that the earliest signs of infection may be written not only in the sequences of viral genomes, but also in the changing architecture and fate of the host cell’s own RNA.
Subject of Research: Cellular RNA homeostasis and MDA5-mediated antiviral immune activation during viral infection
Article Title: Loss of cellular RNA homeostasis contributes to MDA5 activation during virus infection
Article References: Sampaio, N.G., Davis, T., Gearing, L.J. et al. Loss of cellular RNA homeostasis contributes to MDA5 activation during virus infection. Nature Immunology (2026). https://doi.org/10.1038/s41590-026-02614-3
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41590-026-02614-3
Keywords: MDA5, antiviral immunity, RNA homeostasis, double-stranded RNA, interferon, innate immunity, viral infection, RNA surveillance, MAVS, cellular RNA metabolism
Tags: abnormal RNA molecules triggering immune sensorscellular RNA balance and immune activationinnate immune system molecular surveillancelong double-stranded RNA detection mechanismsMAVS-mediated signaling pathway in antiviral responseMDA5 activation in innate immunitymechanisms of MDA5 sensing viral RNAregulation of RNA clearance during viral infectionRIG-I-like receptor family in antiviral defenseRNA homeostasis and immune responserole of interferons in viral infectionviral infection and disruption of cellular RNA processing
